Linked Life Data

17416372

Source:http://linkedlifedata.com/resource/pubmed/id/17416372

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-10-19
pubmed:abstractText
Extra domain A (EDA), splice-variant of fibronectin, is a Toll-like receptor 4 (Tlr4) ligand. Recently, EDA has been demonstrated to enhance atherogenesis in mice but human data on the role of EDA in atherosclerotic disease are lacking. We hypothesized that EDA is associated with unstable plaque phenotypes and that plasma EDA could serve as biomarker for atherosclerosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1879-1484
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
195
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e83-91
pubmed:dateRevised
2007-12-27
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a stable plaque phenotype.
pubmed:affiliation
Experimental Cardiology Laboratory, Cardiology, University Medical Center Utrecht, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't